Merck & Co., the second-largest U.S. drugmaker, forecast first-quarter profit that falls below analysts’ estimates.
First quarter adjusted profit will be 95 cents to 98 cents a share, the Whitehouse Station, New Jersey-based company said today in a statement. That compares with analysts’ estimates of $1.01 a share. The company reaffirmed its 2012 full year adjusted profit of $3.75 to $3.85 a share.
To contact the editor responsible for this story: Will Daley at firstname.lastname@example.org